Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. USO
2. SPY
3. QTTB
4. BIIB
5. AAPL
6. ERAS
7. PSKY
8. JPM
9. MU
10. SPCX

Go back to Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
(NASDAQ: INTS) Delayed: 4.92 +0.14 (2.93%)
Previous Close $4.78    52 Week High $ 
Open $4.85    52 Week Low $ 
Day High $4.95    P/E N/A 
Day Low $4.80    EPS $ 
Volume 46,234